Frank E. Mott

Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy

Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop

ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform

Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

Non-small cell lung cancer clinical trials with trastuzumab: their foundation and preliminary results

Cancer-associated cachexia

Health care professionals’ experience, understanding and perception of need of advanced cancer patients with cachexia and their families: The benefits of a dedicated clinic

The Antiphospholipid Syndrome

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy

Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy

The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancer

Chronic Inflammation and Cytokines in the Tumor Microenvironment

Phase II Study of an Alternate Carboplatin and Gemcitabine Dosing Schedule in Advanced Non–Small-Cell Lung Cancer

Antiphospholipid antibodies and adrenal hemorrhage

Effect of HER2/neu Expression on Survival in Non–Small-Cell Lung Cancer

c-Met targeted therapy of cholangiocarcinoma

Difficult conversations: from diagnosis to death.

Phase 1/2a, open‐label, multicenter study of RM‐1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma